COMMON DEFICIENCIES RAISED BY VARIOUS REGULATORY AGENCIES
Journal Title: International Journal of Drug Regulatory Affairs - Year 2014, Vol 2, Issue 2
Abstract
Timely Product registration is a challenge in today’s scenario. Regulatory agencies are keen in assessing CTD sections like redefining starting material of Drug substance manufacturing, Pharmaceutical development, impurities in Drug substance and Drug product, Container-closure. Common deficiencies are presented in this article.
Authors and Affiliations
Mohidekar S, Maharao V, Badjatya J. K.
WEARABLE HEALTHCARE TECHNOLOGY – THE REGULATORY PERSPECTIVE
The world today isn’t the one which it was yesterday. With the continuing evolution in technology and technological applications on medical field, innovative products and services have been emerging every day. Wearable g...
REGULATORY STRATEGY FOR REGISTRATION OF COMBINATION PRODUCTS TO US-FDA
In pharmaceutical industry all the healthcare products are categorized into Drugs, Devices, and biologics and they are regulated by their respective departments of the regulatory authorities. Due to more and more develop...
IMPORTANCE OF DEFICIENCY RESPONSE IN PHARMACEUTICAL ENVIRONMENT FOR DRUG APPROVAL
This illustrates examples of series deficiencies, that’s how really company faces problem due to deficiency. It’s to convey the message if drug product manufacturer can visualize earlier all aspect of risks and manifest...
A PARADIGM SHIFT IN DRUG REGULATIONS IN TAIWAN
Across Asia, a convergence of economic trends, government policies and greater awareness among the general public of healthcare issues has created an environment that is poised for dramatic growth and change. Taiwan, for...
Integrating PLCM strategy in Pharmaceutical Emerging Market
All products and services must denote definite life cycles. The life cycle talks about the period from the product‘s first launch till it wind-up onto the market. Throughout this age noteworthy modifications are made in...